These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24854879)

  • 1. Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease.
    Nackiewicz D; Dey P; Szczerba B; Mohammad S; Kaplan JL; McNamara CA; Deshmukh US; Bagavant H
    Nephron Exp Nephrol; 2014; 126(3):141-7. PubMed ID: 24854879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of a transcriptional regulator, inhibitor of differentiation 3, induces glomerulonephritis in apolipoprotein E-deficient mice: a model linking hyperlipidemia and renal disease.
    Bagavant H; Scindia Y; Nackiewicz D; Nandula SR; Doran A; Cutchins A; Oldham S; Deshmukh U; McNamara C
    Am J Pathol; 2011 Aug; 179(2):651-60. PubMed ID: 21801865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice.
    Mühlfeld AS; Spencer MW; Hudkins KL; Kirk E; LeBoeuf RC; Alpers CE
    Kidney Int; 2004 Oct; 66(4):1393-402. PubMed ID: 15458432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice.
    Sastre C; Rubio-Navarro A; Buendía I; Gómez-Guerrero C; Blanco J; Mas S; Egido J; Blanco-Colio LM; Ortiz A; Moreno JA
    PLoS One; 2013; 8(12):e83713. PubMed ID: 24386260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.
    Perry HM; Oldham SN; Fahl SP; Que X; Gonen A; Harmon DB; Tsimikas S; Witztum JL; Bender TP; McNamara CA
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2771-9. PubMed ID: 24115031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of scavenger receptor A protects mice from progressive nephropathy independent of lipid control during diet-induced hyperlipidemia.
    Wang W; He B; Shi W; Liang X; Ma J; Shan Z; Hu Z; Danesh FR
    Kidney Int; 2012 May; 81(10):1002-1014. PubMed ID: 22377830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell aortic homing and atheroprotection depend on Id3.
    Doran AC; Lipinski MJ; Oldham SN; Garmey JC; Campbell KA; Skaflen MD; Cutchins A; Lee DJ; Glover DK; Kelly KA; Galkina EV; Ley K; Witztum JL; Tsimikas S; Bender TP; McNamara CA
    Circ Res; 2012 Jan; 110(1):e1-12. PubMed ID: 22034493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans.
    Doran AC; Lehtinen AB; Meller N; Lipinski MJ; Slayton RP; Oldham SN; Skaflen MD; Yeboah J; Rich SS; Bowden DW; McNamara CA
    Circ Res; 2010 Apr; 106(7):1303-11. PubMed ID: 20185798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-like protein 4 promotes hyperlipidemia-induced renal injury by down-regulating the expression of ACTN4.
    Li Y; Gong W; Liu J; Chen X; Suo Y; Yang H; Gao X
    Biochem Biophys Res Commun; 2022 Mar; 595():69-75. PubMed ID: 35101665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Id3 and Id2 act as a dual safety mechanism in regulating the development and population size of innate-like γδ T cells.
    Zhang B; Lin YY; Dai M; Zhuang Y
    J Immunol; 2014 Feb; 192(3):1055-1063. PubMed ID: 24379125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.
    Rosenfeld SM; Perry HM; Gonen A; Prohaska TA; Srikakulapu P; Grewal S; Das D; McSkimming C; Taylor AM; Tsimikas S; Bender TP; Witztum JL; McNamara CA
    Circ Res; 2015 Jul; 117(3):e28-39. PubMed ID: 26082558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of myeloid differentiation protein 2 prevents obesity-induced inflammation and nephropathy.
    Fang Q; Wang L; Yang D; Chen X; Shan X; Zhang Y; Lum H; Wang J; Zhong P; Liang G; Wang Y
    J Cell Mol Med; 2017 Dec; 21(12):3776-3786. PubMed ID: 28767204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice.
    Bruneval P; Bariéty J; Bélair MF; Mandet C; Heudes D; Nicoletti A
    Nephrol Dial Transplant; 2002 Dec; 17(12):2099-107. PubMed ID: 12454219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ID3 may protect mice from anti‑GBM glomerulonephritis by regulating the differentiation of Th17 and Treg cells.
    Zhou H; Wang L; Xu Q; Liu Q; Liu H; Qiu W; Hu T; Lv Y; Zhang Q
    Mol Med Rep; 2017 Dec; 16(6):9086-9094. PubMed ID: 28990057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Null mutation of the transcription factor inhibitor of DNA binding 3 (id3) affects spermatozoal motility parameters and epididymal gene expression in mice.
    Carroll M; Luu T; Robaire B
    Biol Reprod; 2011 Apr; 84(4):765-74. PubMed ID: 21148110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice.
    Tavori H; Fan D; Giunzioni I; Zhu L; Linton MF; Fogo AB; Fazio S
    J Lipid Res; 2014 Oct; 55(10):2073-81. PubMed ID: 25183802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protection of huanglian jiedu decoction on livers of hyperlipidemia mice].
    Ma YL; Li T; Wang BB; Jia B; Chen B; Su J; Wang XB; Zeng H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Aug; 33(8):1107-11. PubMed ID: 24325064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Id3 increases VCAM-1 expression, macrophage accumulation, and atherogenesis in Ldlr-/- mice.
    Lipinski MJ; Campbell KA; Duong SQ; Welch TJ; Garmey JC; Doran AC; Skaflen MD; Oldham SN; Kelly KA; McNamara CA
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2855-61. PubMed ID: 23042815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion.
    Cutchins A; Harmon DB; Kirby JL; Doran AC; Oldham SN; Skaflen M; Klibanov AL; Meller N; Keller SR; Garmey J; McNamara CA
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):317-24. PubMed ID: 22075252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.